药物治疗对慢性鼻窦炎认知功能障碍的影响
这项前瞻性研究纳入27例成人慢性鼻窦炎患者,在给予适当药物治疗前及治疗6周后评估认知功能、疲劳及工作效率。治疗后疲劳严重度量表、匹兹堡睡眠质量指数、认知失败问卷及部分客观神经认知测试改善,工作效率无显著变化。作者认为适当药物治疗可改善慢性鼻窦炎患者的若干认知功能障碍指标,结果需更大规模、更长程研究评估可持续性。
要点
- 27例成人慢性鼻窦炎患者接受适当药物治疗6周后,疲劳严重度量表评分从4.32±1.78降至3.28±1.65(p=0.003)。
- 认知失败问卷评分从38.56±16.40降至33.04±14.35(p=0.046),匹兹堡睡眠质量指数从8.62±5.06降至6.85±4.11(p=0.014)。
- 客观神经认知测试中数学加工和Stroop反应测试第3块改善,工作效率指标无显著变化。
核心结论
- 适当的药物治疗可改善慢性鼻窦炎患者的若干认知功能障碍指标。
- 作者认为结果的可持续性应通过更大规模、更长程的研究评估。
研究设计与样本
- 前瞻性研究,纳入27例成人慢性鼻窦炎患者,在适当药物治疗前完成生活质量与神经认知测试,治疗6周后复查。
主要发现
- 疲劳严重度量表评分从治疗前4.32±1.78降至治疗后3.28±1.65(p=0.003)。
- 匹兹堡睡眠质量指数从治疗前8.62±5.06降至治疗后6.85±4.11(p=0.014)。
- 认知失败问卷评分从治疗前38.56±16.40降至治疗后33.04±14.35(p=0.046)。
- 数学加工测试从治疗前19.79±5.61升至治疗后21.3±6.87(p=0.029);Stroop反应测试第3块从治疗前43.06±15.66升至治疗后50.42±19.34(p=0.002)。
- 工作效率指标无显著变化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者认为结果的可持续性应通过更大规模、更长程的研究评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cognitive dysfunction in chronic rhinosinusitis (CRS) is often overlooked despite potentially broad implications. Earlier work has demonstrated decreased cognitive function in CRS patients at baseline. In this study we sought to prospectively evaluate the impact of initial, appropriate medical therapy on subjective and objective cognitive function, fatigue, and workplace productivity. METHODS: Adult patients with CRS were prospectively enrolled and completed a robust battery of pretreatment quality-of-life and neurocognitive testing, before undergoing appropriate medical therapy with follow-up testing at 6 weeks. Patient-reported cognitive function was assessed using the Cognitive Failures Questionnaire (CFQ), whereas fatigue was measured with the Fatigue Severity Scale (FSS). Objective cognitive function was assessed using the Automated Neuropsychological Assessment Metrics (ANAM) platform and workplace productivity using the Clinical Trials version of the World Health Organization Health and Work Performance Questionnaire (ctHPQ). RESULTS: Twenty-seven patients were enrolled. Patients demonstrated posttreatment improvement scores on the FSS (4.32 ± 1.78 to 3.28 ± 1.65; p = 0.003), Pittsburgh Sleep Quality Index (8.62 ± 5.06 to 6.85 ± 4.11; p = 0.014), and CFQ (38.56 ± 16.40 to 33.04 ± 14.35; p = 0.046). Objective neurocognitive tests of mathematical processing and Stroop Reaction Test Block 3 improved after medical therapy (19.79 ± 5.61 to 21.3 ± 6.87; p = 0.029 and 43.06 ± 15.66 to 50.42 ± 19.34; p = 0.002, respectively). Measures of workplace productivity did not change significantly. CONCLUSION: Appropriate medical therapy improves several measures of cognitive dysfunction in patients with CRS. Sustainability of results should be evaluated with larger, prolonged studies.
引用
- Rowan NR, Schlosser RJ, Storck KA, et al. The impact of medical therapy on cognitive dysfunction in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019. PMID: 30811873. doi:10.1002/alr.22323
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。